E
Vanda Pharmaceuticals Inc. VNDA
$4.36 $0.051.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -512.58% -805.05% -853.29% -239.24% -173.32%
Total Depreciation and Amortization 33.91% 72.90% 170.17% 190.93% 126.94%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -809.38% -199.26% -80.46% -125.00% -89.71%
Change in Net Operating Assets 381.37% 2.27% -777.91% 9.36% -117.28%
Cash from Operations -1,160.40% -393.95% -223.09% -168.10% -112.59%
Capital Expenditure 98.95% 97.64% 95.33% -26,725.19% -20,264.80%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -27.72% 141.40% -114.28% -62.61% 25.28%
Cash from Investing 206.55% 120.54% -44.58% -160.85% -183.79%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -- --
Foreign Exchange rate Adjustments 5,000.00% -733.33% -446.81% 136.25% -100.38%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 53.33% 94.17% -4,330.43% -161.81% -151.31%